Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olav Mella

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|December 9, 2004
[Should complementary therapies be offered in hospitals?]Terje Risberg, Yngve Bremnes, Arne Kolstad, et al.
BMC Cancer|August 8, 2008
AIDS-related primary central nervous system lymphoma: a Norwegian national survey 1989-2003Ingfrid S Haldorsen, Jostein Kråkenes, Anne K Goplen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 4, 2008
Hyperthermia improves the antitumour effect of metronomic cyclophosphamide in a rat transplantable brain tumourErling Dahl Borkamo, Oystein Fluge, Olav Mella, et al.
International Journal of Radiation Oncology, Biology, Physics|November 26, 2009
cDNA microarray analysis of serially sampled cervical cancer specimens from patients treated with thermochemoradiotherapyErling Dahl Borkamo, Baard-Christian Schem, Øystein Fluge, et al.
Acta Oncologica (Stockholm, Sweden)|September 17, 2004
Incidence, clinical features, treatment and outcome of primary central nervous system lymphoma in NorwayIngfrid Salvesen Haldorsen, Jan Harald Aarseth, Aase Hollender, et al.
Plos One|February 2, 2023
Endothelial dysfunction in ME/CFS patientsMiriam Kristine Sandvik, Kari Sørland, Elisabeth Leirgul, et al.
Plos One|August 19, 2016
Serum BAFF and APRIL Levels, T-Lymphocyte Subsets, and Immunoglobulins after B-Cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Myalgic Encephalopathy/Chronic Fatigue SyndromeSigrid Lunde, Einar K Kristoffersen, Dipak Sapkota, et al.
Frontiers in Medicine|April 8, 2021
Reduced Endothelial Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome-Results From Open-Label Cyclophosphamide Intervention StudyKari Sørland, Miriam Kristine Sandvik, Ingrid Gurvin Rekeland, et al.
Cancer|August 28, 2007
Increasing incidence and continued dismal outcome of primary central nervous system lymphoma in Norway 1989-2003 : time trends in a 15-year national surveyIngfrid S Haldorsen, Bård K Krossnes, Jan H Aarseth, et al.
Clinical Therapeutics|December 4, 2018
Rituximab Serum Concentrations and Anti-Rituximab Antibodies During B-Cell Depletion Therapy for Myalgic Encephalopathy/Chronic Fatigue SyndromeIngrid G Rekeland, Øystein Fluge, Kine Alme, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|December 9, 2004
[Should complementary therapies be offered in hospitals?]Terje Risberg, Yngve Bremnes, Arne Kolstad, et al.
BMC Cancer|August 8, 2008
AIDS-related primary central nervous system lymphoma: a Norwegian national survey 1989-2003Ingfrid S Haldorsen, Jostein Kråkenes, Anne K Goplen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 4, 2008
Hyperthermia improves the antitumour effect of metronomic cyclophosphamide in a rat transplantable brain tumourErling Dahl Borkamo, Oystein Fluge, Olav Mella, et al.
International Journal of Radiation Oncology, Biology, Physics|November 26, 2009
cDNA microarray analysis of serially sampled cervical cancer specimens from patients treated with thermochemoradiotherapyErling Dahl Borkamo, Baard-Christian Schem, Øystein Fluge, et al.
Acta Oncologica (Stockholm, Sweden)|September 17, 2004
Incidence, clinical features, treatment and outcome of primary central nervous system lymphoma in NorwayIngfrid Salvesen Haldorsen, Jan Harald Aarseth, Aase Hollender, et al.
Plos One|February 2, 2023
Endothelial dysfunction in ME/CFS patientsMiriam Kristine Sandvik, Kari Sørland, Elisabeth Leirgul, et al.
Plos One|August 19, 2016
Serum BAFF and APRIL Levels, T-Lymphocyte Subsets, and Immunoglobulins after B-Cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Myalgic Encephalopathy/Chronic Fatigue SyndromeSigrid Lunde, Einar K Kristoffersen, Dipak Sapkota, et al.
Frontiers in Medicine|April 8, 2021
Reduced Endothelial Function in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome-Results From Open-Label Cyclophosphamide Intervention StudyKari Sørland, Miriam Kristine Sandvik, Ingrid Gurvin Rekeland, et al.
Cancer|August 28, 2007
Increasing incidence and continued dismal outcome of primary central nervous system lymphoma in Norway 1989-2003 : time trends in a 15-year national surveyIngfrid S Haldorsen, Bård K Krossnes, Jan H Aarseth, et al.
Clinical Therapeutics|December 4, 2018
Rituximab Serum Concentrations and Anti-Rituximab Antibodies During B-Cell Depletion Therapy for Myalgic Encephalopathy/Chronic Fatigue SyndromeIngrid G Rekeland, Øystein Fluge, Kine Alme, et al.
Pageof 5